RT Journal Article
SR Electronic
A1 Zarifyan, Alla
T1 Percutaneous Treatment of Valvular Heart Disease, Atrial Fibrillation Examined in Various Studies
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 5
SP 5
OP 7
DO 10.1177/1559897715583650
UL http://mdc.sagepub.com/content/15/5/5.abstract
AB PARTNER 1 demonstrated that patients at high risk of surgery had a similar mortality at 5 years with transcatheter versus surgical aortic valve replacement, while the CoreValve US Pivotal Trial showed that transcatheter aortic valve replacement reduced mortality at 2 years when compared with surgical aortic valve replacement. Observational data showed that patients treated with MitraClip had improvements in mitral regurgitation. The AATAC-AF study showed that catheter ablation is superior to amiodarone in treating persistent atrial fibrillation.